Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in TaxesChange in TaxesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Change in Intangibles (2021 - 2024)

Trinity Biotech's Change in Intangibles history spans 4 years, with the latest figure at -$2.6 million for Q4 2024.

  • On a quarterly basis, Change in Intangibles fell 302.34% to -$2.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$4.4 million, a 56.31% decrease, with the full-year FY2024 number at -$9.7 million, down 408.1% from a year prior.
  • Change in Intangibles hit -$2.6 million in Q4 2024 for Trinity Biotech, down from -$641000.0 in the prior quarter.
  • Over the last five years, Change in Intangibles for TRIB hit a ceiling of -$1658.0 in Q2 2022 and a floor of -$2.6 million in Q4 2024.
  • Historically, Change in Intangibles has averaged -$910800.0 across 4 years, with a median of -$652000.0 in 2022.
  • Biggest five-year swings in Change in Intangibles: skyrocketed 65.2% in 2022 and later tumbled 302.34% in 2024.
  • Tracing TRIB's Change in Intangibles over 4 years: stood at -$1.9 million in 2021, then skyrocketed by 65.2% to -$663000.0 in 2022, then increased by 3.32% to -$641000.0 in 2023, then crashed by 302.34% to -$2.6 million in 2024.
  • Business Quant data shows Change in Intangibles for TRIB at -$2.6 million in Q4 2024, -$641000.0 in Q4 2023, and -$492000.0 in Q3 2023.